Turner Andrew L
Director at STRM; Director at Actavis plc; Director at WATSON PHARMACEUTICALS INC
- Sold, on record
- $4.7M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jan 20, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- STRMSTREAMLINE HEALTH SOLUTIONS INC.Director
- Actavis plcDirector
- WATSON PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- STRM67,527 shares
- WATSON PHARMACEUTICALS INC57,501 shares
- Actavis plc5,441 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale WATSON PHARMACEUTICALS INCUnusualMay 29 2012
Sold 20,000 shares at $73.59 ($1.5M)
Turner Andrew L, Director
Sold 76.7% of holdings ($1.9M position)6,064 shares left4.4x usual sizeFiling
- 2 Form 4 sale WATSON PHARMACEUTICALS INCUnusualMar 4 +279 days
Sold 2,500 shares at $85.76 ($214k)
Turner Andrew L, Director
Sold 41.2% of holdings ($520k position)3,564 shares left0.4x usual sizeFiling
- 3 Form 4 sale Actavis plcUnusualNov 4 +245 days
Sold 2,677 shares at $156.48 ($419k)
Turner Andrew L, Director
Sold 49.2% of holdings ($851k position)2,764 shares leftFirst sale on recordFiling
- 4 Form 4 sale Actavis plcUnusualNov 22 +18 days
Sold 2,500 shares at $163.45 ($409k)
Turner Andrew L, Director
Sold 90.4% of holdings ($452k position)264 shares leftFiling
- 5 Form 4 sale Actavis plcUnusualDec 5 +13 days
Sold 264 shares at $162.43 ($43k)
Turner Andrew L, Director
Sold 100% of holdings ($43k position)0 shares leftFiling
- 6 Form 4 sale STRMPlan not statedDec 27 +22 days
Sold 25,000 shares at $6.63 ($166k)
Turner Andrew L, Director
Sold 20.4% of holdings ($812k position)97,527 shares leftFirst sale on recordFiling
- 7 Form 4 sale STRMPlan not statedSep 23 +270 days
Sold 17,567 shares at $3.83 ($67k)
Turner Andrew L, Director
Sold 16.4% of holdings ($410k position)89,513 shares leftFiling
- 8 Form 4 sale STRMUnusualJan 20 +119 days
Sold 24,960 shares at $3.54 ($88k)
Turner Andrew L, Director
Sold 27.9% of holdings ($317k position)64,553 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2015 | STRM | Director | Form 4 sale | 24,960 | $88k | 27.9% | Unusual | SEC |
| Sep 23, 2014 | STRM | Director | Form 4 sale | 17,567 | $67k | 16.4% | Plan not stated | SEC |
| Dec 27, 2013 | STRM | Director | Form 4 sale | 25,000 | $166k | 20.4% | Plan not stated | SEC |
| Dec 5, 2013 | Actavis plc | Director | Form 4 sale | 264 | $43k | 100.0% | Unusual | SEC |
| Nov 22, 2013 | Actavis plc | Director | Form 4 sale | 2,500 | $409k | 90.4% | Unusual | SEC |
| Nov 4, 2013 | Actavis plc | Director | Form 4 sale | 2,677 | $419k | 49.2% | Unusual | SEC |
| Mar 4, 2013 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 2,500 | $214k | 41.2% | Unusual | SEC |
| May 29, 2012 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 20,000 | $1.5M | 76.7% | Unusual | SEC |
| Nov 15, 2011 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 10,000 | $658k | 75.9% | Unusual | SEC |
| Sep 14, 2011 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 4,000 | $264k | 55.7% | Unusual | SEC |
| Aug 15, 2011 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 1,000 | $65k | 12.2% | Plan not stated | SEC |
| Jun 11, 2010 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $213k | 50.0% | Unusual | SEC |
| Mar 15, 2010 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $206k | 50.0% | Unusual | SEC |
| Dec 10, 2009 | WATSON PHARMACEUTICALS INC | Director | Form 4 sale | 10,001 | $382k | 66.7% | Unusual | SEC |